Kalvista Pharmaceuticals Inc (KALV)
Operating Cash Flow Growth
63.20%
TTM · Period ending:
KALV Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported63.20%period ending
Latest reported63.20%period ending
KALV TTM Cash from Operations YoY % (-153.31% → 63.20%)
Year-over-year change
High-resolution chart · PNG
KALV operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 63.1972% | |
| -11.245% | |
| -30.7578% | |
| -62.7603% | |
| -71.3608% | |
| -31.9196% | |
| -56.1391% | |
| -29.618% | |
| -18.5621% | |
| -21.845% | |
| 6.7823% | |
| 4.6812% | |
| 3.677% | |
| -27.2864% | |
| -50.5786% | |
| -87.601% | |
| -158.9705% | |
| -96.5411% | |
| -50.0282% | |
| -19.3622% | |
| 32.6781% | |
| 25.6737% | |
| 7.8826% | |
| 10.377% | |
| -23.2394% | |
| -34.267% | |
| -656.7084% | |
| -571.0939% | |
| -444.4308% | |
| -329.3036% | |
| 150.6085% | |
| 200.8921% | |
| 191.5838% | |
| 199.2897% | |
| 24.5323% | |
| 61.6312% | |
| 47.3548% | |
| 33.0334% | |
| 5.4935% | |
| -25.849% | |
| -61.6327% | |
| -85.3994% | |
| -153.309% |